During the month of August, one ASE member, Cassady Palmer, BS, ACS, RDCS, RDMS, FASE, was recognized for Going the Extra Mile and received a GEM award!z

Her nominator said, “Cassady has made some tremendous strides in the name of research for our lab. Cassady and our Medical Director, Dr Mazur, have secured a large research grant that will support and propel their work for years to come. Needless to say, we are very proud.”

Do you know an ASE member who’s gone the extra mile? Join us in celebrating ASE members who are making the world a better place, be it for their dedication to the field of cardiovascular ultrasound, being an outstanding mentor to students or fellows, their commitment to quality patient care, a milestone service anniversary, or congratulating them on a major accomplishment. Learn more about how to nominate someone here.

Join Guideline Chair, Amer M. Johri, MD, FASE, and Henrik Sillesen, MD, DMSc, for a free, LIVE webinar, Tuesday, September 22, 1:00 – 2:00 PM EDT, as they review the recently published ASE guideline, Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk. They will discuss the advantages and disadvantages of two-dimensional (2D) and three-dimensional (3D) ultrasound methods for carotid arterial plaque quantification.

1. To register, login to your ASE member portal.
2. Select the ASE Learning Hub from the top red menu.
3. Register for the webinar here.

By the end of this educational webinar, viewers will be able to:

• Understand the standard method for carotid arterial plaque quantification recommended by ASE using 2-D or 3-D derived plaque height.
• Become familiar with other methods of arterial plaque measurement such as plaque score, plaque area, and plaque volume, including their advantages and disadvantages.
• Understand the clinical context within which carotid arterial plaque quantification enhances cardiovascular risk stratification.
• Become familiar with emerging techniques for carotid arterial plaque composition assessment and its role in detecting the vulnerable patient.

The latest issue of CASE, ASE’s online case reports journal, is available and contains, “Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome,” by James M. Horowitz, MD, Eugene Yuriditsky, MD, Ian J. Henderson, MD, Maxine Wallis Stachel, MD, Benjamin Kwok, MD, and Muhamed Saric, MD, PhD, FASE. Lead author Dr. Horowitz said, “Thrombotic events are common among patients with COVID-19. A high index of suspicion for pulmonary embolism should be maintained among patients with respiratory or hemodynamic decompensation. We reported a clot-in-transit in such a case using transesophageal echocardiography allowing for immediate bedside diagnosis with the patient maintained in prone position.”

Takotsubo cardiomyopathies, rheumatic heart disease, transesophageal surgical situations, anatomic anomalies, masses, myxomas, thrombus, and interventional image guidance (both in human and animal patients) are other topics explored. One of the interventional image guidance cases looks at the novel use of echo fusion and cardiac computed tomographic imaging guidance for percutaneous paravalvular leak closure and comes from Lucy M. Safi, DO, FASE, FACC, et al.

CASE is a valuable tool for mentors, educators, and sonographers to utilize while elevating everyone’s detective abilities. CASE co-Editors-in-Chief, L. Leonardo Rodriguez, MD, FASE, and Karen G. Zimmerman, BS, ACS, RDCS, RVT, FASE, are very grateful to the all the authors and reviewers who have dedicated their time and effort to helping CASE continue its mission of publishing high-quality educational content. “We hope that the CASE community remains safe and engaged as we move forward in uncharted waters.”

CASE always wants to hear from readers and potential authors with opinions and questions. Don’t hesitate to email managing editor, Deborah Meyer at DMeyer@ASEcho.org.

Thank you to everyone who submitted images for the ASE 2021 Image Calendar Competition. Now it is time to vote for your favorite images to be featured in a colorful, 12-month calendar that will be sent to all members who renew by December 31, 2020. Help your friends and colleagues win by voting today.

To vote for your favorite echo images:

1. Login to Connect@ASE.
2. Browse the images uploaded in the  ASE 2021 Calendar Contest Image Library.
3. Click each image to view.
4. Give the “thumbs up” to as many images as you would like. The thumbs up button is located below the title of the image and author.

Each thumbs up counts as one vote. If you have any questions, please contact ASE at ACooper@ASEcho.org. Your input helps to create a beautiful and interesting 2021 image calendar

Durham, NC, August 8, 2020 – The World Alliance of Societies of Echocardiography (WASE) Normal Values Study is a cross-sectional study designed to obtain universal global reference ranges for both 2D and 3D echocardiographic (2DE, 3DE) data to identify geographical differences in echocardiographic measurements. Launched in 2016, the WASE study prospectively enrolled healthy individuals free from cardiac, lung, and kidney disease from 19 centers in 15 countries.

A new research study, using the data collected in the WASE study, examined the 2DE images and 3DE full-volume datasets obtained in a total of 1026 adults (351 non-Asian and 675 Asian), analyzed offline in two Core Labs. First author on the research, Laurie Soulat-Dufour, said of the findings, “Currently there is a paucity of data on 2D and 3D right atrial dimensions in the literature. Our results suggest that normal reference values for 2D and 3D end-systolic right atrial volumes are not universal and that population specific normal values should be established for different geographic groups.” Read more here.

The American Society of Echocardiography (ASE) will host its 31st Annual Scientific Sessions as a Virtual Experience online August 8-10, 2020. Over 350 posters featuring cutting-edge research on the advances in cardiovascular ultrasound will be presented. A special group of investigators were selected as the ASE Foundation’s Top 20. These early career abstract presenters were selected by the Scientific Sessions Program Committee Abstract Chairs based on the scientific merit of their research projects and were awarded complimentary registration to the ASE 2020 Virtual Experience from the Foundation.

Michael Main, MD, FASE, from Saint Luke’s Mid America Heart Institute, Kansas City, MO, and ASE 2020 Abstract Chair said, “The abstracts selected for presentation at our Scientific Sessions represent the very best cardiovascular imaging research in the United States—and around the world. The breadth and depth of these presentations is truly remarkable, and includes novel applications of advanced technologies such as three-dimensional imaging, ultrasound enhancing agents, and artificial intelligence in both pediatric and adult populations.” Read more here.

Two research studies being presented at the ASE 2020 Virtual Experience, August 8-10, 2020, highlight the use of artificial intelligence (AI) software to provide real-time guidance to users with no prior training in ultrasound acquisition.  Read more here.

From point of care ultrasound that has been a key technology during the COVID-19 pandemic to robust technology that is enhancing efficiency and clinical care, over 20 companies and organizations will display their latest products and services at the world’s premier meeting for cardiovascular ultrasound practitioners, the ASE 2020 Virtual Experience. This virtual event, which promises a wealth of cutting edge education, research, and the latest vendor technology, is taking place August 8-10, 2020. Read more here.

ASE is a strong proponent for innovation in the field of ultrasound and has been actively engaged in fostering artificial intelligence (AI) to assist guidance of optimal image acquisition for cardiovascular ultrasound. We believe this type of innovation could be an ally to help meet the demands of a growing number of people who are in need of cardiovascular care as obesity and diabetes levels continue to rise around the world. Computer assisted guidance of optimal image acquisition can support sonographers in obtaining high-quality image acquisition following the guidelines and standards for the optimal practice of echocardiography. The Society believes vigorous scientific protocols are needed when creating these AI algorithms as the end products need to take into account many factors including gender, ethnicity, age, etc. that research has shown can dramatically change the testing outcomes.

We applaud the vision of newer industry innovators, such as Ultromics and Caption Health, as well as legacy ultrasound companies including Canon Medical Systems, GE Healthcare, Hitachi Healthcare, Philips, and Siemens Healthineers, who are dedicated to the continued development and adoption of high-quality echocardiography to better support patient-centered care. ASE engages with industry through multiple avenues, including technology summits, think tanks, and our Industry Roundtable program, to ensure that the future of cardiovascular ultrasound is driven by clinical standards of excellence. ASE will continue to set the standards for image analysis, including the quantitative parameters required, expected reliability of measurements, and how these measures are integrated to provide clinical insight.

Last week, ASE welcomed 31 new distinguished Fellows of the American Society of Echocardiography (FASE) designation recipients! These members have exemplified excellence through education, research, leadership, and volunteerism. They are ambassadors for ASE, and recognized experts in their field. A full list of FASE members can be found on SeeMyHeart.org. If you are interested in applying for FASE, or would like more information, please visit ASEcho.org/FASE. Join us in congratulating the newest FASE recipients:

Wilbur Jeremiah Asheld, DO, FASE
Faisal D. Arain, MBBS, MD, FASE
Sujatha P. Bhandary, MD, FASE
Michael L. Boisen, MD, FASE
Laura T. Boone, RDCS, RVT, RDMS, RT(R), FASE
Christopher Brockway, MS, RDCS, FASE
Sindu Chandran, MD, FACC, FACP, FASE
Jacqueline Suk Danik, MD, DrPH, FASE
Garrett J. De Francis, BS, RDCS, FASE
Mary Frances Duncan, RDCS, FASE
Elliott Elias, MD, MPH, FASE
Marie Ficociello, MA, RDCS, FASE
Suzette Blondelle Graham-Hill, MD, FACP, FASE
Sarah Ann Chambers Gurson, MD, FASE
Sonia A. Henry, MD, FACC, FASE
Arunima Misra, MD, FASE
Shaine A. Morris, MD, MPH, FASE
Akhil Narang, MD, FASE
Nirvik Pal, MD, MBBS, FASE
Atif Nazier Qasim, MD, MSCE, FASE
Sahadev T. Reddy, MD, FACC, FASE
Albert R. Robinson III, MD, FASE
Karen Scholz, BAPPSci, Grad Dip(Cardiac Ultrasound), FASE
Jeffrey Mohl Scott, DO, FACEP, EDIC, FASE
Rhonda Smith-Hudson, MS, RDCS, FASE
Stephanie N. Stewart, MS, RDCS, RVT, FASE
Devorah M. Taylor, RDCS, RVT, FASE
Justin W Ulrich, MBA, ACS, RCS, RDCS, RVT, RCIS, CCT, FASE
Mani Vindhya, MD, FASA, FASE
John Joseph Wilbur Asheld III, DO, FASE
Michael Young, RDCS, RVT, AAS, FASE